Recent Finacing
Recent Raise
Synvect develops CRISPR-based sterile male mosquito suppression products (non‑gene‑drive), holds U.S. EPA approval for SEPARATOR, and runs pilot deployments with government and mosquito-control agencies in high-risk U.S. regions.
